Respiratory Muscle Strength and Exercise Capacity in Smokers
NCT ID: NCT06650150
Last Updated: 2025-08-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
150 participants
OBSERVATIONAL
2024-10-20
2025-07-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Respiratory Muscle Strength in Patients With Idiopathic Pulmonary Fibrosis
NCT03588260
Comparison of Patients With COPD and PRISM
NCT07249567
The Effect of Clinical Parameters on Muscle Oxygenation in Patients With COPD
NCT06041126
Muscle Oxygenation in Chronic Obstructive Pulmonary Disease
NCT05808621
Effectiveness of Personalized Breathing Exercise Device in Patients With COPD
NCT06259188
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
PRISm
cigarette smokers with FEV1 below 80%
maximal inspiratory pressure
maximal inspiratory pressure (mip) will be measured with a specific device
maximal expiratory pressure
MEP will be measured with a specific device
6 minute walk test
6mwt will be done by a phsyotherapist
preCOPD
cigarette smokers with normal pft
maximal inspiratory pressure
maximal inspiratory pressure (mip) will be measured with a specific device
maximal expiratory pressure
MEP will be measured with a specific device
6 minute walk test
6mwt will be done by a phsyotherapist
COPD
cigarette smokers with FEV1/FVC less than 70%
maximal inspiratory pressure
maximal inspiratory pressure (mip) will be measured with a specific device
maximal expiratory pressure
MEP will be measured with a specific device
6 minute walk test
6mwt will be done by a phsyotherapist
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
maximal inspiratory pressure
maximal inspiratory pressure (mip) will be measured with a specific device
maximal expiratory pressure
MEP will be measured with a specific device
6 minute walk test
6mwt will be done by a phsyotherapist
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Presence of chronic respiratory diseases (Asthma, IPF, Bronchiectasis, \[except COPD\])
* Exacerbation due to chronic respiratory diseases (except mild COPD exacerbation)
* Neuromuscular disease (ALS, Guillain-Bare syndrome, Muscular dystrophies, Myasthenia gravis)
* Restrictive pulmonary disease (IPF, Sarcoidozis, Progresif Pulmonary Fibrosis)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Muğla Sıtkı Koçman University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sabri Serhan OLCAY
Assistant Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Muğla Training and Research Hospital
Muğla, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MIP24
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.